Did he possibly say ADT and the second generation ARSIs (ending in "-lutamide", like Apalutamide or Enzalutamide)? Those definitely work better together, as many studies have demonstrated.

They're all hormone therapy, but they work differently: ADT like Lupron or Orgovyx blocks testosterone production, while ARSI blocks testosterone reception by the cancer cells, so you're attacking it at both ends.